Logo image
Associations between testing and treatment pathways in lesional temporal or extratemporal epilepsy: A census survey of NAEC center directors
Journal article   Open access   Peer reviewed

Associations between testing and treatment pathways in lesional temporal or extratemporal epilepsy: A census survey of NAEC center directors

Christopher W Beatty, Stephanie M Ahrens, Kristen H Arredondo, Anto I Bagić, Shasha Bai, Kevin E Chapman, Michael A Ciliberto, Dave F Clarke, Mariah Eisner, Nathan B Fountain, …
Epilepsia (Copenhagen), Vol.64(4), pp.821-830
04/2023
DOI: 10.1111/epi.17512
PMID: 36654194
url
https://doi.org/10.1111/epi.17512View
Published (Version of record) Open Access

Abstract

The evaluation to determine candidacy and treatment for epilepsy surgery in persons with drug-resistant epilepsy (DRE) is not uniform. Many non-invasive and invasive tests are available to ascertain an appropriate treatment strategy. This study examines expert response to clinical vignettes of MRI-positive lesional focal cortical dysplasia in both temporal and extratemporal epilepsy to identify associations in evaluations and treatment choice. We analyzed annual report data and a supplemental epilepsy practice survey reported in 2020 from 206 adult and 136 pediatric epilepsy center directors in the United States. Non-invasive and invasive testing and surgical treatment strategies were compiled for the two scenarios. We used chi-square tests to compare testing utilization between the two scenarios. Multivariable logistic regression modeling was performed to assess associations between variables. The supplemental survey response rate was 100% with 342 responses included in the analyses. Differing testing and treatment approaches were noted between the temporal and extratemporal scenarios such as chronic invasive monitoring selected in 60% of the temporal scenario versus 93% of the extratemporal scenario. Open resection was the most common treatment choice, however overall treatment choices varied significantly (p<0.001). Associations between non-invasive testing, invasive testing, and treatment choices were present in both scenarios. For example, in the temporal scenario SEEG was more commonly associated with FDG-PET (OR 1.85; 95% CI 1.06-3.29; p=0.033), MEG (OR 2.90; 95% CI 1.60-5.28; p = <0.001), HD EEG (OR 2.80; 95% CI 1.27-6.24; p = 0.011), fMRI (OR 2.17; 95% CI 1.19-4.10; p = 0.014) and Wada (OR 2.16; 95% CI 1.28-3.66; p = 0.004). In the extratemporal scenario, choosing SEEG was associated with increased odds of neuromodulation over open resection (OR 3.13; 95% CI 1.24-7.89; p=0.016). In clinical vignettes of temporal and extratemporal lesional DRE, epilepsy center directors displayed varying patterns of non-invasive testing, invasive testing, and treatment choices. Differences in practice underscore the need for comparative trials for the surgical management of DRE.
Epilepsy Surgery Drug Resistant Epilepsy (DRE) Temporal Lobe Epilepsy (TLE)

Details

Metrics

Logo image